MIV Therapeutics Inc. Announces Participation at TCT 2008 in Washington, D.C.

ATLANTA & FRANKFURT, Germany--(BUSINESS WIRE)--MIV Therapeutics, Inc. (OTCBB:MIVI) (Frankfurt:MIV), a leading developer of next-generation coatings and advanced drug-delivery systems for cardiovascular stents and other implantable medical devices, announced today its participation at the Transcatheter Cardiovascular Therapeutics (TCT) 2008 conference. The conference will be held on October 12-17 at the Washington Convention Center in Washington, D.C.